EKF Diagnostics (LON:EKF) Reaches New 1-Year Low – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKFGet Free Report)’s share price hit a new 52-week low on Thursday . The company traded as low as GBX 23 ($0.29) and last traded at GBX 24.50 ($0.30), with a volume of 678077 shares trading hands. The stock had previously closed at GBX 24.70 ($0.31).

EKF Diagnostics Trading Down 0.8 %

The business’s 50 day simple moving average is GBX 25.92 and its two-hundred day simple moving average is GBX 27.10. The stock has a market cap of £108.90 million, a P/E ratio of 22.80 and a beta of 0.57. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34.

About EKF Diagnostics

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Further Reading

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.